Mawer Investment Management Ltd. lifted its holdings in Zoetis Inc. (NYSE:ZTS – Free Report) by 21.9% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 313,562 shares of the company’s stock after acquiring an additional 56,377 shares during the quarter. Mawer Investment Management Ltd.’s holdings in Zoetis were worth $21,896,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also made changes to their positions in ZTS. Diversified Trust Co boosted its holdings in Zoetis by 45.0% during the third quarter. Diversified Trust Co now owns 13,093 shares of the company’s stock worth $914,000 after buying an additional 4,066 shares in the last quarter. Allworth Financial LP increased its position in shares of Zoetis by 14.5% in the third quarter. Allworth Financial LP now owns 7,622 shares of the company’s stock worth $548,000 after acquiring an additional 964 shares in the last quarter. Fifth Third Bancorp acquired a new stake in shares of Zoetis during the third quarter valued at approximately $7,352,000. Bingham Private Wealth LLC acquired a new stake in shares of Zoetis during the third quarter valued at approximately $277,000. Finally, Maryland State Retirement & Pension System raised its holdings in shares of Zoetis by 13.3% during the third quarter. Maryland State Retirement & Pension System now owns 24,879 shares of the company’s stock valued at $1,737,000 after acquiring an additional 2,918 shares during the period. 92.80% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of equities analysts recently commented on ZTS shares. William Blair lowered shares of Zoetis from an “outperform” rating to a “market perform” rating in a research note on Thursday, August 6th. Zacks Research upgraded shares of Zoetis from a “strong sell” rating to a “hold” rating in a research report on Monday, October 26th. BTIG Research dropped coverage on shares of Zoetis in a research note on Friday, October 30th. They set a “buy” rating and a $200.00 target price on the stock. TD Cowen reduced their target price on Zoetis from $104.00 to $94.00 and set a “buy” rating for the company in a report on Tuesday, August 25th. Finally, JPMorgan Chase & Co. reduced their target price on Zoetis from $130.00 to $115.00 and set an “overweight” rating for the company in a report on Friday, August 7th. Eight research analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $101.25.
View Our Latest Stock Report on Zoetis
Zoetis Stock Up 0.8%
NYSE ZTS traded up $0.69 during trading on Friday, reaching $83.65. 3,151,935 shares of the company’s stock were exchanged, compared to its average volume of 4,644,448. The company has a current ratio of 2.35, a quick ratio of 1.40 and a debt-to-equity ratio of 2.51. Zoetis Inc. has a fifty-two week low of $68.77 and a fifty-two week high of $132.49. The company’s fifty day simple moving average is $76.28 and its 200-day simple moving average is $91.56. The firm has a market capitalization of $33.99 billion, a PE ratio of 14.23, a P/E/G ratio of 1.20 and a beta of 0.67.
Zoetis (NYSE:ZTS – Get Free Report) last posted its quarterly earnings results on Thursday, November 5th. The company reported $1.75 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.51 by $0.24. The business had revenue of $2.39 billion during the quarter, compared to analyst estimates of $2.30 billion. Zoetis had a net margin of 26.15% and a return on equity of 85.90%. The firm’s revenue was down 1.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.70 earnings per share. Sell-side analysts predict that Zoetis Inc. will post 6.29 EPS for the current year.
Zoetis Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 1st. Investors of record on Friday, October 30th will be given a dividend of $0.53 per share. The ex-dividend date of this dividend is Friday, October 30th. This represents a $2.12 dividend on an annualized basis and a yield of 2.5%. Zoetis’s payout ratio is presently 36.05%.
About Zoetis
Zoetis is an animal health company that discovers, develops, manufactures and markets medicines, vaccines, diagnostic products and other services for animals. Its products support both companion animals, such as dogs and cats, and livestock, including cattle, pigs, poultry, sheep and fish. The company’s offerings include treatments for pain, infections and skin conditions, as well as vaccines, parasiticides, diagnostic tools and genetic testing services. Zoetis serves veterinarians, livestock producers and other animal health professionals around the world.
Featured Articles
- Five stocks we like better than Zoetis
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS – Free Report).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.
